AbbVie (ABBV) Dividends Paid - Common (2013 - 2026)
AbbVie (ABBV) posted quarterly Dividends Paid - Common of $3.1 billion for Q1 2026, up 5.5% year-over-year from $2.9 billion in Q1 2025, and up 6.01% quarter-over-quarter from $2.9 billion in Q4 2025.
AbbVie (ABBV) Dividends Paid - Common (2013 - 2026) Analysis & Trends
AbbVie (ABBV) has reported Dividends Paid - Common for 14 consecutive years, with $3.1 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Dividends Paid - Common rose 5.5% year-over-year to $3.1 billion; the TTM figure through Mar 2026 stood at $11.8 billion (up 5.73% YoY), while the FY2025 annual figure was $11.7 billion, up 5.73% from the prior year.
- Dividends Paid - Common grew to $3.1 billion in Q1 2026 per ABBV's latest filing, from $2.9 billion in the prior quarter.
- Across five years, Dividends Paid - Common topped out at $3.1 billion in Q1 2026 and bottomed at $2.5 billion in Q3 2022.
- Historically, Dividends Paid - Common has averaged $2.7 billion across 5 years, with a median of $2.8 billion in 2024.
- Annual changes were most pronounced in 2022 — Dividends Paid - Common gained 8.79% — and 2024, when it rose 4.17%.
- AbbVie's Dividends Paid - Common stood at $2.5 billion in 2022, then rose by 4.79% to $2.6 billion in 2023, then gained by 4.8% to $2.8 billion in 2024, then increased by 5.78% to $2.9 billion in 2025, then gained by 6.01% to $3.1 billion in 2026.
- Business Quant data shows ABBV's Dividends Paid - Common at $3.1 billion in Q1 2026, $2.9 billion in Q4 2025, and $2.9 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Paid (Common) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 3.23 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 3.07 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 2.14 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 2.87 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | 6.58 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 1.36 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | 1.03 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | 2.45 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | - |
| 10 | Sanofi | 55.07 Bn | 47.69 Bn | 10.79 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.07 Bn |
| Jun 30, 2026 | 3.07 Bn |
| Mar 31, 2026 | 3.09 Bn |
| Mar 31, 2026 | 3.09 Bn |
| Dec 31, 2025 | 2.91 Bn |
| Dec 31, 2025 | 2.91 Bn |
| Sep 30, 2025 | 2.91 Bn |
| Sep 30, 2025 | 2.91 Bn |
| Jun 30, 2025 | 2.91 Bn |
| Jun 30, 2025 | 2.91 Bn |
| Mar 31, 2025 | 2.93 Bn |
| Mar 31, 2025 | 2.93 Bn |
| Dec 31, 2024 | 2.75 Bn |
| Dec 31, 2024 | 2.75 Bn |
| Sep 30, 2024 | 2.75 Bn |
| Sep 30, 2024 | 2.75 Bn |
| Jun 30, 2024 | 2.75 Bn |
| Jun 30, 2024 | 2.75 Bn |
| Mar 31, 2024 | 2.77 Bn |
| Mar 31, 2024 | 2.77 Bn |